Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 26, 2023	Aug. 27, 2022
Operating Activities
Net earnings	$ 56,903	$ 60,120
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	20,661	21,448
Share-based compensation	4,483	3,394
Deferred income taxes	(4,281)	6,858
Gain on disposal of assets	(62)	(695)
Proceeds from New Markets Tax Credit transaction, net of deferred costs	0	18,390
Settlement of New Markets Tax Credit transaction	(4,687)	(19,523)
Noncash lease expense	6,153	6,160
Other, net	(1,121)	3,836
Changes in operating assets and liabilities:
Receivables	(8,238)	(71,720)
Inventories	5,841	(17,636)
Contract assets	8,992	6,754
Accounts payable and accrued expenses	(21,096)	(11,793)
Contract liabilities	4,244	20,927
Refundable and accrued income taxes	4,292	(20,486)
Operating lease liability	(6,608)	(6,684)
Prepaid expenses and other current assets	(2,912)	(1,993)
Net cash provided (used) by operating activities	62,564	(2,643)
Investing Activities
Capital expenditures	(15,018)	(9,255)
Proceeds from sales of property, plant and equipment	143	4,122
Purchases of marketable securities	(969)	0
Sales/maturities of marketable securities	775	450
Net cash used by investing activities	(15,069)	(4,683)
Financing Activities
Borrowings on line of credit	174,853	409,880
Repayment on debt	0	(151,000)
Payments on line of credit	(199,000)	(171,000)
Payments on debt issue costs	0	(687)
Repurchase and retirement of common stock	(11,821)	(74,312)
Dividends paid	(10,467)	(9,602)
Other, net	(3,705)	(2,815)
Net cash (used) provided by financing activities	(50,140)	464
Decrease in cash, cash equivalents and restricted cash	(2,645)	(6,862)
Effect of exchange rates on cash	(405)	28
Cash, cash equivalents and restricted cash at beginning of year	21,473	37,583
Cash and cash equivalents at end of period	18,423	30,749
Noncash Activity
Capital expenditures in accounts payable	$ 2,493	$ 2,019